<DOC>
	<DOCNO>NCT01582906</DOCNO>
	<brief_summary>After treatment woman survive gynaecological cancer may experience lateeffects longterm challenge specific disease treatment result functional deficit reduction societal integration ( Yabroff et al. , 2004 , Yadav , 2007 ) . The available research best model posttreatment rehabilitation support woman posttreatment gynaecological cancer limit . The primary objective study determine additional benefit , usual rehabilitation care , additional rehabilitation appointment develop survivorship care plan cancer specific health relate quality life . Secondary objective determine additional benefit general selfefficacy , generic health relate quality life social health economics patient complete treatment stage I II gynaecological cancer . Also explore patient 's perspective intervention . The study open patient attend outpatient gynaecological clinic Royal Marsden NHS Foundation Trust recently complete treatment Stage I II gynaecological cancer . They report experience physical psychosocial need result disease treatment ; age 18 year willing able articulate need . The study last six month participant . It involve complete questionnaire attend two extra rehabilitation appointment develop survivorship care plan hospital may also include attend interview involve study randomise intervention group</brief_summary>
	<brief_title>A Survivorship Care Plan Gynaecological Cancer Patients</brief_title>
	<detailed_description>Purpose design We conduct preliminary qualitative study last year ( Rec Ref 10/H0608/56 ) gynaecological patient report unmet rehabilitation care need , physical psychosocial . At end treatment patient say unaware resolve need . They also report wanted support information manage consequence cancer treatment rather become 'overmedicalised ' require treatment professional , possible ( Sandsund et al. , 2011 ) . Since yet body evidence prove best model delivery develop study reflect intervention participant study suggest would best support . During preliminary study participant make suggestion may improve journey treatment . Of five focus group suggest meet clinic rehabilitation professional end treatment explore rehabilitation need . The intervention describe defined patient preliminary study . After study analyse present Rehabilitation Research Group discussion start regard research question design interventional study . The Head Therapies , representative Psychological Care/ Psychological Support Service Nurse Consultant Living Beyond Cancer involve development protocol preliminary study order ensure ' conduct feasible within The Royal Marsden NHS Foundation Trust ( RM ) . There discussion amongst research group author best way clinically screen physical psychosocial problem . The FACTG , EORTC Distress Thermometer thoroughly consider . The Distress Thermometer choose question felt best cover issue felt participant group may . It use National Cancer Survivorship Initiative/ Department Health project RM one sit . evaluation project find clinically useful screen tool acceptable patient . The European Organisation Research Treatment Cancer Quality life Questionnaire - C30 ( EORTC QLQC30 ) , General Self Efficacy Scale ( GSES ) , Short Form 36 ( SF36 ) choose wide use rehabilitation intervention study ability detect change time reliably cancer population . We believe primary outcome measure EORTC sensitive enough detect change due intervention . The statistician give advice regard provide statistical support study date . A Health Economist involve study RM develop study specific form measure economic evaluation impact health social care provision . She perform cost analysis information see intervention health social economic impact . The patient 's perspective intervention seek use qualitative interview randomise sample complete study . This used ass acceptability intervention patient .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<criteria>Participants : diagnosis complete initial treatment Stage I II gynaecological cancer ; recently complete treatment pathway radical intent ; receive primary treatment The Royal Marsden NHS Foundation Trust ( RM ) ; report experience physical psychosocial need result disease 's treatment ; age 18 year ; willing able articulate need . Those eligible endoflife care , metastatic disease lack capacity understand purpose study participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>